Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
27.97
-0.25 (-0.89%)
Sep 6, 2024, 3:00 PM CST
Tianjin Pharmaceutical Da Ren Tang Group Corporation Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 921.94 | 986.71 | 861.79 | 769.14 | 661.7 | 625.57 | Upgrade
|
Depreciation & Amortization | 125.08 | 127.78 | 116.56 | 115.53 | 110.85 | 98.15 | Upgrade
|
Other Amortization | 6.1 | 5.37 | 4.11 | 2.26 | 2.71 | 3.09 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.05 | -0.15 | -1.08 | -12.32 | -7.54 | -29.94 | Upgrade
|
Asset Writedown & Restructuring Costs | 44.36 | 44.36 | 20.16 | 1.93 | 0.92 | 0.78 | Upgrade
|
Loss (Gain) From Sale of Investments | -241.89 | -308.11 | -274.22 | -213.49 | -160.41 | -182.73 | Upgrade
|
Provision & Write-off of Bad Debts | 22.41 | 19.09 | 9.22 | 4.89 | 6.35 | -0.35 | Upgrade
|
Other Operating Activities | 46.71 | 38.92 | 54.02 | 32.68 | 17.81 | 43.33 | Upgrade
|
Change in Accounts Receivable | -152.53 | 74.01 | -732.29 | -42.07 | -113.81 | -102.7 | Upgrade
|
Change in Inventory | 90.06 | -165.34 | 58.87 | -47.4 | 110.96 | -292.56 | Upgrade
|
Change in Accounts Payable | 358.85 | -56.06 | 609.67 | 220.2 | 13.81 | 380.44 | Upgrade
|
Change in Other Net Operating Assets | -18.98 | -18.98 | 6.82 | 10.15 | 9.75 | - | Upgrade
|
Operating Cash Flow | 1,121 | 688.49 | 677.25 | 852.4 | 671.42 | 495.49 | Upgrade
|
Operating Cash Flow Growth | 57.79% | 1.66% | -20.55% | 26.95% | 35.51% | 41.51% | Upgrade
|
Capital Expenditures | -113.14 | -140.93 | -107.9 | -156.95 | -189.16 | -205.61 | Upgrade
|
Sale of Property, Plant & Equipment | 0.08 | 0.19 | 1.49 | 28.71 | 6.77 | 38.35 | Upgrade
|
Cash Acquisitions | - | - | -47.61 | - | - | - | Upgrade
|
Investment in Securities | -146 | -606.35 | -65.08 | -334.92 | 41.05 | -98.05 | Upgrade
|
Other Investing Activities | 242.41 | 178.18 | 206.82 | 151.3 | 215.12 | 164.53 | Upgrade
|
Investing Cash Flow | -16.65 | -568.91 | -12.28 | -311.85 | 73.77 | -100.79 | Upgrade
|
Long-Term Debt Issued | - | 870.86 | 205.65 | - | - | 130 | Upgrade
|
Total Debt Issued | 1,117 | 870.86 | 205.65 | - | - | 130 | Upgrade
|
Long-Term Debt Repaid | - | -807.34 | -39.87 | -1.42 | -1.1 | -353.14 | Upgrade
|
Total Debt Repaid | -861.09 | -807.34 | -39.87 | -1.42 | -1.1 | -353.14 | Upgrade
|
Net Debt Issued (Repaid) | 256.16 | 63.52 | 165.78 | -1.42 | -1.1 | -223.14 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 8.36 | 28.3 | Upgrade
|
Repurchase of Common Stock | -3.39 | -22.67 | - | -1.35 | -0.7 | - | Upgrade
|
Common Dividends Paid | -22.28 | -877.33 | -387.43 | -232.06 | -232.61 | -173.35 | Upgrade
|
Other Financing Activities | 0.07 | 2.7 | -14.96 | -9.87 | -11.21 | -2.16 | Upgrade
|
Financing Cash Flow | 230.56 | -833.77 | -236.62 | -244.7 | -237.26 | -370.36 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.8 | 0.05 | 0.01 | - | - | - | Upgrade
|
Net Cash Flow | 1,336 | -714.15 | 428.35 | 295.85 | 507.93 | 24.34 | Upgrade
|
Free Cash Flow | 1,008 | 547.56 | 569.34 | 695.45 | 482.26 | 289.87 | Upgrade
|
Free Cash Flow Growth | 70.57% | -3.83% | -18.13% | 44.21% | 66.37% | 66.27% | Upgrade
|
Free Cash Flow Margin | 12.45% | 6.66% | 6.90% | 10.07% | 7.30% | 4.14% | Upgrade
|
Free Cash Flow Per Share | 1.30 | 0.71 | 0.73 | 0.90 | 0.63 | 0.38 | Upgrade
|
Cash Income Tax Paid | 730.97 | 765.94 | 526.93 | 496.73 | 522.98 | 598.75 | Upgrade
|
Levered Free Cash Flow | 1,857 | 365.73 | 961.19 | 149.46 | 270.91 | 364.73 | Upgrade
|
Unlevered Free Cash Flow | 1,880 | 388.14 | 967.61 | 151.29 | 270.92 | 367.78 | Upgrade
|
Change in Net Working Capital | -1,335 | 122.61 | -535.27 | 176.45 | -2.12 | -142.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.